Articles
1 February 1994

Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12)

Publication: Annals of Internal Medicine
Volume 120, Number 3

Abstract

Objective:

To evaluate protein-bound cyanocobalamin (vitamin B12) sub absorption before and after omeprazole (Prilosec) therapy in healthy male volunteers.

Design:

Clinical trial in which each volunteer served as his own control.

Setting:

Outpatient department of a university medical center.

Participants:

Ten healthy, male volunteers 22 to 50 years old.

Intervention:

Each participant had a modified Schilling test (protein-bound cyanocobalamin) and a gastric analysis, as well as measurements of serum vitamin B12, gastrin, and folate levels. Five patients were then randomly assigned to take either 20 mg or 40 mg of omeprazole daily. After 2 weeks of omeprazole therapy, these tests were repeated.

Measurements:

The modified Schilling test, gastric analysis, serum gastrin level, folate level, and cyanocobalamin level.

Results:

At the end of the 2-week treatment period, cyanocobalamin absorption decreased from 3.2% to 0.9% (P = 0.031) in participants receiving 20 mg of omeprazole daily. In patients taking 40 mg of omeprazole daily, cyanocobalamin absorption decreased from 3.4% to 0.4% (P < 0.05).

Conclusions:

Omeprazole therapy acutely decreased cyanocobalamin absorption in a dose-dependent manner.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole—a gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man. Gut. 1983; 24:270-6.
2.
Koop H. Review article: Metabolic consequences of long-term inhibition of acid secretion by omeprazole. Aliment Pharmacol Ther. 1992; 6:399-406.
3.
Maton PN, Vinayek R, Frucht H, McArthur KA, Miller LS, Saeed ZA, et al. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology. 1989; 97:827-36.
4.
Lee GR. Megaloblastic and nonmegaloblastic macrocytic anemias. In: Wintrobe MM, Lee GR, Bithell TC, Foester J, Athens JW, Lukens JN, eds. Wintrobe's Clinical Hematology. 9th ed. Philadelphia: Lea and Febiger; 1993:745-90.
5.
Herbert V. Don't ignore low serum cobalamin (vitamin B12) levels (Editorial). Arch Intern Med. 1988; 148:1705-7.
6.
Herzlich B, Herbert V. Rapid collection of human intrinsic factor uncontaminated with cobalophilin (R binder). Am J Gastroenterol. 1986; 81:678-80.
7.
Herzlich B, Herbert V. The role of the pancreas in cobalamin (vitamin B12) absorption. Am J Gastroenterol. 1984; 79:489-93.
8.
Neale G. B12 binding proteins. Gut. 1990; 31:59-63.
9.
Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, et al. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase. Nature. 1981; 290:159-61.
10.
Fellenius E, Elander B, Wallmark B, Helander HF, Berglindh T. Inhibition of acid secretion in isolated glands by substituted benzimidazoles. Am J Physiol. 1982; 243:G505-10.
11.
Wallmark B, Jaresten B-M, Larsson H, Ryberg B, Bramdstrom A, Fellenius E. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion. Am J Physiol. 1983; 245:G64-71.
12.
Saccomani G, Helander HF, Crago S, Chang HH, Dailey DW, Sachs G. Characterization of gastric mucosal membranes. X. Immunological studies of gastric (H+ + K+) ATPase. J Cell Biol. 1979; 83(2 Pt 1):271-83.
13.
Forte JF, Lee HC. Gastric adenosine triphosphatases: a review of their possible role in HCl secretion. Gastroenterology. 1977; 73: 921-6.
14.
Kittang E, Aaland E, Schjonsby H. Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man. Gut. 1985; 26:594-8.
15.
Herbert V, Drivas G, Manusselis C, Mackler B, Eng J, Schwartz E. Are colon bacteria a major source of cobalaminanalogues in human tissues? 24-hr human stool contains only about 5 µg of apparent analogue (and 200 µg of folate). Trans Assoc Am Physicians. 1984; 97:161-71.
16.
King CE, Leibach T, Toskes PP. Clinically significant vitamin B12 deficiency secondary to malabsorption of protein-bound vitamin B12. Dig Dis Sci. 1979; 24:397-402.
17.
Gottlieb C, Lau KS, Wasserman LR, Herbert V. Rapid charcoal assay for human intrinsic factor (IF), gastric juice unsaturated B12 binding capacity, antibody to IF, and serum unsaturated B12 binding capacity. Blood. 1965; 25:875-85.
18.
Kemp JA, Golner BB, Russell RM. Effect of an acidic dietary drink on absorption of protein-bound vitamin B12 (Abstract). Gastroenterology. 1992; 102:560A.
19.
Koop H, Bachem MG. Serum iron, ferritin and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992; 14:288-92.
20.
Kittang E, Aadland E, Schjonsby H, Rohss K. The effect of omeprazole on gastric acidity and the absorption of liver cobalamins. Scand J Gastroenterol. 1987; 22:156-60.
21.
Streeter AM, Duraiappali B, Boyle R, O'Neill BJ, Pheils MT. Malabsorption of vitamin B12 after vagotomy. Am J Surg. 1974; 128: 340-3.
22.
Doscherholmen A, Swaim WR. Impaired assimilation of egg Co57 -vitamin B12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology. 1973; 64:913-9.
23.
King CE, Leibach J, Toskes PP. Clinically significant vitamin B12 deficiency secondary to malabsorption of protein-bound vitamin B12. Dig Dis Sci. 1979; 24:397-402.
24.
Streeter AM, Goulston KJ, Bathur FA, Hilmer RS, Crane GG, Pheils MT. Cimetidine and malabsorption of cobalamin. Dig Dis Sci. 1982; 27:13-6.
25.
Belaiche J, Cattan D, Zittoun J, Marquet J, Yvart J. Effect of ranitidine on cobalamin absorption (Letter). Dig Dis Sci. 1983:28: 667-8.
26.
Steinberg WM, King CE, Toskes PP. Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Dig Dis Sci. 1980; 25:188-91.
27.
Salom IL, Silvis SE, Doscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scand J Gastroenterol. 1982; 17:129-31.
28.
Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NA, Raymond F, et al. Twenty-four hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther. 1987; 1:239-51.
29.
Yale CE, Gohdes PN, Schilling RF. Cobalamin absorption and hematologic status after two types of gastric surgery for obesity. Am J Hematol. 1993; 42:63-6.
30.
Marcuard SP, Sinar DR, Swanson MS, Silverman JF, Levine JS. Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci. 1989; 34:1238-42.
31.
Suter PM, Golner BB, Goldin BR, Morrow FD, Russell RM. Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology. 1991; 101:1039-45.
32.
Festen HP, Tuynman HA, Den Hollander W, Menwissen SG. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action. Aliment Pharmacol Ther. 1989; 3:375-9.
33.
Mohammed R, Clark JS, Adams JF, Hearns JB, Crean GP. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion. Clin Ther. 1981; 4:118-20.
34.
Yeomans ND, Hanson RG, Smallwood RA, Mihaly GW, Louis WJ. Effect of chronic ranitidine treatment on secretion of intrinsic factor. Br Med J (Clin Res Ed). 1982; 285:264.
35.
Belaiche J, Zittoun J, Marquet J, Nurit Y, Yvart J. (Effect of ranitidine on secretion of gastric intrinsic factor and absorption of vitamin B12). Gastroenterol Clin Biol. 1983; 7:381-4.

Comments

0 Comments
Sign In to Submit A Comment

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 120Number 31 February 1994
Pages: 211 - 215

History

Published in issue: 1 February 1994
Published online: 15 August 2000

Keywords

Authors

Affiliations

Stefan P. Marcuard, MD
From East Carolina University School of Medicine, Greenville, North Carolina.
Lisa Albernaz, RN
From East Carolina University School of Medicine, Greenville, North Carolina.
Prabhaker G. Khazanie, PhD
From East Carolina University School of Medicine, Greenville, North Carolina.
Corresponding Author: Stefan P. Marcuard, MD, Section of Gastroenterology, Department of Medicine, East Carolina University School of Medicine, Greenville, NC 287858-4354.
Acknowledgments: The authors thank the Human Health Division of Merck, Inc. for its support; and the Department of Medicines, Text/Information Processing Center for preparation of the manuscript.
Grant Support: In part by grant 585451 from the American College of Gastroenterology.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Stefan P. Marcuard, Lisa Albernaz, Prabhaker G. Khazanie. Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12). Ann Intern Med.1994;120:211-215. doi:10.7326/0003-4819-120-3-199402010-00006

View More

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/EPUB

View PDF/EPUB

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media